article thumbnail

STAT’s most memorable photos of 2022

STAT

Reflecting back on our favorite photographs from 2022, we are struck by how many portraits were in our selection. These images also document a pipeline program for Indigenous medical students, an incarcerated person fighting for better hepatitis C care, and a trailblazing Alzheimer’s researcher.

article thumbnail

UK ATMP clinical trials report 2022 published

European Pharmaceutical Review

The Cell and Gene Therapy (CGT) Catapult has published its ‘ UK Advanced Therapy Medicinal Products (ATMP) Clinical Trials Report 2022 ’. The research observed this cell type took up 58 percent of UK ATMP clinical trials in 2022. . The number of Phase II/III trials increased from three trials in 2021 to seven trials in 2022.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

STAT+: Hospital systems’ investment income perked up at end of 2022

STAT

Large hospital systems’ investments rebounded heavily in the final quarter of 2022, according to a new STAT analysis of financial filings. STAT analyzed the financial documents of 37 tax-exempt, not-for-profit health systems covering the last three months of 2022.

article thumbnail

Intas Pharmaceuticals under FDA scrutiny after oversight in GMP documents

Pharmafile

India-based manufacturer Intas Pharmaceuticals has been issued a Form 483 by the FDA after three investigators found a “cascade of failure” in a site inspection carried out at their manufacturing facility in Pharmez Special Economic Zone (SEZ) between late November and early December 2022. read more

article thumbnail

2022 WHO Biosimilar Guideline improves access, IGBA says

European Pharmaceutical Review

The International Generic and Biosimilar Medicines Association (IGBA)’s new whitepaper Embracing Science with Confidence: Adopting the Revised 2022 WHO Biosimilars Guideline suggests how the guideline provides great opportunity to revaluate how regulatory requirements can better advance biosimilar access. WHO Biosimilar Guideline updates.

article thumbnail

Examining the US Response to the Mpox Outbreak

Drug Topics

By way of natural immunity, vaccination, and behavior change, the majority of the 30,861 documented cases and 54 deaths were confined to 2022, and the epidemic curve portrays a picture of success.

article thumbnail

Victor Alves Presenting at the 2022 Northeast Conference

OctariusRx

OctariusRx President and Consultant Pharmacist Victor Alves is presenting “Medication Management: Acing your next Survey” at the 2022 Northeast Conference, presented by the Massachusetts Association of Ambulatory Surgery Centers. The post Victor Alves Presenting at the 2022 Northeast Conference appeared first on OctariusRX.